Skip to content

Epidural Analgesia During Labour

Epidural Analgesia During Labour Randomized Clinical Trial Comparing Patient Controlled Epidural Analgesia Versus Patient Intermittent Epidural Boluses With Levobupivacaine

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03133091
Acronym
PIEBvsPCEA
Enrollment
200
Registered
2017-04-28
Start date
2015-09-30
Completion date
2017-09-30
Last updated
2018-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Epidural, Anesthesia, Obstetrical

Keywords

PIEB, PCEA, LEVOBUPIVACAINE

Brief summary

Randomized single blind trial based on comparing the way the local anesthetic is dosificated during labour. The pain control is evaluated and compared with both dosage techniques (PCEA vs PIEB)using levobupivacaine and fentanyl. The primary objective is to see no differences in pain control(VAS, Visual Analog Scale). The secondary goals are the differences in motor block(Bromage Scale), satisfaction (Likert Scale), the outcome (eutocic, instrumental o cesarean section), second stage of labour time, newborn´s Apgar and pH and total dosis and secondary effects of local anesthetic.

Detailed description

There is a protocol where every healthy primiparous women have the chance to join the study after the explanation and the informed consent is signed. There are blind envelopes with the two kinds of treatment and the investigator only has to follow the protocol.

Interventions

DRUGPIEB: Patient Intermittent Epidural Boluses

Each patient were randomized to PIEB (7 ml bolus every 30 minutes, with extra boluses (PCEA) of 6 ml every 20 minutes) or PCEA (5 ml in continuous perfussion + PCEA of 5 ml every 15 minutes).

DRUGPCEA: Patient Controlled Epidural Analgesia

Each patient were randomized to PIEB (7 ml bolus every 30 minutes, with extra boluses (PCEA) of 6 ml every 20 minutes) or PCEA (5 ml in continuous perfussion + PCEA of 5 ml every 15 minutes).

Sponsors

Hospital del Rio Hortega
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* 20- 40 years-old women * Primiparous women * Dilatation 3- 7 cm * No risk illnesses for epidural block * No risk pregnancy * Signed informed consent

Exclusion criteria

* Illnesses which are a risk for pregnancy * Multiparous women * Contraindicated diseases for epidural block * Women who can not understand the procedure * Women who do not want to sign the informed consent * Patients with drug´s allergy

Design outcomes

Primary

MeasureTime frameDescription
VAS4 times after epidural block: previous, 1 hour after, 2 hours after, 15 minutes after deliveryChange from baseline in Visual Analog Scale

Secondary

MeasureTime frameDescription
Bromage Scale15 minutes after Epidural Block and 1 hour after epidural block
Labour OutcomeDeliveryEutocic
Expulsive timeFrom 10 cm of dilatation until delivery
Satisfaction (Likert Scale)1 hour after delivery1 (very satisfied), 2 (satisfied), 3 (no comments), 4 (not very satisfied), 5 (not satisfied at all)
fetal pH at birth0 minutes after delivery0 minutes after delivery
Total Dosis of Levobupivacaine0 minutes after deliverymiligrams
Apgar at birth1 minute after birthApgar measured in 1 minute

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026